Skip to contentLEE KENNETH B JR — INSPIRE PHARMACEUTICALS INC insider: 232 transactions · InsiderLensLEE KENNETH B JR
- Director at POZEN INC /NC · on record since Jan 5, 2006
- Director at INSPIRE PHARMACEUTICALS INC · on record since Jun 14, 2006
- Director at CV THERAPEUTICS INC · on record since Jun 7, 2006
- Director at ABGENIX INC · on record since Apr 4, 2006
- Director at OSI PHARMACEUTICALS INC · on record since Jun 15, 2007
- Director at MAXYGEN INC · on record since Sep 24, 2009
- Director at BIOCRYST PHARMACEUTICALS INC · on record since Jun 28, 2011
- Director at Aralez Pharmaceuticals Inc. · on record since Feb 9, 2016
- 10% owner at Clearside Biomedical, Inc. · on record since Jun 7, 2016
- 10% owner at G1 Therapeutics, Inc. · on record since May 24, 2017
- Director at HYPERION DEFI, INC. · on record since Apr 5, 2018
- 10% owner at PhaseBio Pharmaceuticals Inc · on record since Oct 24, 2018
Insider trading activity of LEE KENNETH B JR
- Transactions on record
- 232
- since Sep 11, 2003
- Open-market buys
- 15
- $1.6M
- Open-market sells
- 3
- $355.8K
- Companies traded
- 11
- last filing Jun 15, 2023
Figures computed from official regulatory filings — methodology.
Companies where LEE KENNETH B JR has traded
- BIOCRYST PHARMACEUTICALS INC24 tx · $421.1K · Jun 15, 2023
- HYPERION DEFI, INC.14 tx · $54.5K · Jun 21, 2022
- PhaseBio Pharmaceuticals Inc37 tx · $1.5M · Oct 24, 2018
- G1 Therapeutics, Inc.2 tx · Dec 4, 2017
- Aralez Pharmaceuticals Inc.10 tx · $26.1K · May 12, 2017
- POZEN INC /NC43 tx · $1.4M · Jun 25, 2015
- MAXYGEN INC8 tx · $15.7K · Jun 7, 2012
- INSPIRE PHARMACEUTICALS INC55 tx · $19.8K · May 16, 2011
- OSI PHARMACEUTICALS INC10 tx · $2.4M · Jun 7, 2010
Track record of LEE KENNETH B JR
Statistical track record
Free- Open-market buys
- 15
- Last buy
- May 19, 2022
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of LEE KENNETH B JR
Co-insiders of LEE KENNETH B JR
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
24 tx · $1.7M · Apr 16, 2009
SHAFFER CHRISTY LClearside Biomedical, Inc. +2
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 15, 2023 | Award | 16,745 | 0.00 USD | $0 | SEC |
| Jun 15, 2023 | AwardD | 39,072 | 0.00 USD | $0 | SEC |
| Feb 2, 2023 | ExerciseD | -15,000 | 0.00 USD | $0 | SEC |
| Feb 2, 2023 | Exercise | 15,000 | 1.71 USD | $25.7K | SEC |
| Jun 21, 2022 | AwardD | 30,769 | 0.00 USD | $0 | SEC |
| Jun 21, 2022 | Award | 22,222 | 0.00 USD | $0 | SEC |
| Jun 9, 2022 | Award | 12,866 | 0.00 USD | $0 | SEC |
| Jun 9, 2022 | AwardD | 30,022 | 0.00 USD | $0 | SEC |
| May 23, 2022 | Buy | 10,000 | 2.20 USD | $22K | SEC |
| Nov 22, 2021 | AwardD | 9,653 | 0.00 USD | $0 | SEC |
| Nov 22, 2021 | Award | 6,963 | 0.00 USD | $0 | SEC |
| Sep 15, 2021 | ExerciseD | -15,000 | 0.00 USD | $0 | SEC |
| Sep 15, 2021 | Sell | -6,000 | 15.35 USD | $92.1K | SEC |
| Sep 15, 2021 | Exercise | 15,000 | 3.22 USD | $48.3K | SEC |
| Jun 15, 2021 | Buy | 2,000 | 5.38 USD | $10.8K | SEC |
| Jun 15, 2021 | Buy | 2,000 | 5.41 USD | $10.8K | SEC |
| Jun 15, 2021 | Buy | 2,000 | 5.47 USD | $10.9K | SEC |
| May 27, 2021 | AwardD | 40,000 | 0.00 USD | $0 | SEC |
| Sep 15, 2020 | AwardD | 9,820 | 0.00 USD | $0 | SEC |
| Sep 15, 2020 | Award | 7,288 | 0.00 USD | $0 | SEC |
| May 14, 2020 | AwardD | 40,000 | 0.00 USD | $0 | SEC |
| Nov 18, 2019 | Buy | 5,000 | 1.45 USD | $7.3K | SEC |
| Aug 20, 2019 | AwardD | 9,057 | 0.00 USD | $0 | SEC |
| Aug 20, 2019 | Award | 8,038 | 0.00 USD | $0 | SEC |
| May 31, 2019 | AwardD | 30,000 | 0.00 USD | $0 | SEC |